A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
University of Colorado, Denver
NiKang Therapeutics, Inc.
EMD Serono
Regor Pharmaceuticals Inc.
Pliant Therapeutics, Inc.
Eli Lilly and Company
MOMA Therapeutics
Eli Lilly and Company
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
AstraZeneca
Mersana Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Nammi Therapeutics Inc
Exscientia AI Limited
Fate Therapeutics
Conjupro Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Conjupro Biotherapeutics, Inc.
Arcus Biosciences, Inc.
Sotio Biotech Inc.
National Cancer Institute (NCI)
SystImmune Inc.
M.D. Anderson Cancer Center
Institut Paoli-Calmettes
Atavistik Bio, Inc
NiKang Therapeutics, Inc.
Alterome Therapeutics, Inc.
ViroMissile, Inc.
Accent Therapeutics
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Normunity AccelCo, Inc.
Poseida Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
Avacta Life Sciences Ltd
SystImmune Inc.
SN BioScience
M.D. Anderson Cancer Center
Eli Lilly and Company
Shanghai Best-Link Bioscience, LLC
University of Washington
Seagen Inc.
Fusion Pharmaceuticals Inc.
Innate Pharma
Dren Bio